Autoimmune haemolytic anaemia and antiphospholipid antibodies in paediatrics: a systematic review and meta-analysis

dc.contributor.authorMerashli, Mira
dc.contributor.authorArcaro, Alessia
dc.contributor.authorGraf, Maria
dc.contributor.authorGentile, Fabrizio
dc.contributor.authorAmes, Paul R.J.
dc.contributor.departmentInternal Medicine
dc.contributor.departmentRheumatology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:43:15Z
dc.date.available2025-01-24T11:43:15Z
dc.date.issued2021
dc.description.abstractIntroduction/objective: The relationship between autoimmune haemolytic anaemia (AIHA) and antiphospholipid antibodies (aPL) has never been addressed via a meta-analysis in the paediatric age group. We evaluated the link between AIHA and aPL in childhood systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Methods: EMBASE and PubMed were screened from inception to May 2020 and Peto’s odds ratio for rare events was employed for the between group comparisons. Results: The meta-analysis included 11 articles for a total of 575 children: the pooled prevalence of AIHA was greater in (1) IgG aCL–positive than IgG aCL–negative children (39.7% vs 20.9%, p = 0.005); (2) in APS-positive than APS-negative SLE children (36.8% vs 13.2%, p = 0.01); and (3) in SLE-related APS than in primary APS children (53% vs 16.2%, p = 0.008). Conclusions: The pooled prevalence of AIHA is greatest in SLE with aPL/APS, low-moderate in SLE without aPL/APS, and lowest in primary APS.Key Points• Antiphospholipid antibodies strongly relate to autoimmune haemolytic anaemia.• Autoimmune haemolytic anaemia is more common in systemic lupus erythematosus with antiphospholipid antibodies. © 2020, International League of Associations for Rheumatology (ILAR).
dc.identifier.doihttps://doi.org/10.1007/s10067-020-05436-2
dc.identifier.eid2-s2.0-85091737949
dc.identifier.pmid33006737
dc.identifier.urihttp://hdl.handle.net/10938/30246
dc.language.isoen
dc.publisherSpringer Science and Business Media Deutschland GmbH
dc.relation.ispartofClinical Rheumatology
dc.sourceScopus
dc.subjectAntiphospholipid syndrome
dc.subjectAutoimmune haemolytic anaemia
dc.subjectLupus
dc.subjectAnemia, hemolytic, autoimmune
dc.subjectAntibodies, antiphospholipid
dc.subjectChild
dc.subjectHumans
dc.subjectLupus erythematosus, systemic
dc.subjectPediatrics
dc.subjectImmunoglobulin g
dc.subjectPhospholipid antibody
dc.subjectAdolescent
dc.subjectArticle
dc.subjectAutoimmune hemolytic anemia
dc.subjectCohort analysis
dc.subjectCoombs test
dc.subjectFemale
dc.subjectFollow up
dc.subjectHuman
dc.subjectMale
dc.subjectMeta analysis
dc.subjectPrevalence
dc.subjectPriority journal
dc.subjectProtein expression
dc.subjectSystematic review
dc.subjectSystemic lupus erythematosus
dc.subjectComplication
dc.titleAutoimmune haemolytic anaemia and antiphospholipid antibodies in paediatrics: a systematic review and meta-analysis
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021-2633.pdf
Size:
360.83 KB
Format:
Adobe Portable Document Format